Ahmed Al-Chalabi, MBCHB

Ahmed Al-Chalabi practices at CHI Health University Campus Emergency Department - Emergency Department - HOPD in Omaha, Nebraska.

Ahmed Al-Chalabi's NPI, 1801286711, was assigned on January 30, 2015. Ahmed Al-Chalabi holds Nebraska license 34764.

Ahmed Al-Chalabi's primary practice is CHI Health University Campus Emergency Department - Emergency Department - HOPD, at 2412 Cuming St, Omaha, NE 68131.

Ahmed Al-Chalabi's primary practice is CHI Health University Campus Emergency Department - Emergency Department - HOPD in Omaha, Nebraska. Ahmed Al-Chalabi is also affiliated with CHI Health Creighton University Medical Center - Bergan Mercy. The medical group on file is CHI Health Clinic. Dmand AI also links Ahmed Al-Chalabi to 4 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Ahmed Al-Chalabi practices, 8 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Ahmed Al-Chalabi's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Ahmed Al-Chalabi's licenses on file in 3 states: Nebraska, Kentucky and Ohio.

CMS data shows 469 Medicare services from Ahmed Al-Chalabi across 15 procedure codes in 2024, for 276 Medicare patients. Medicare paid $53,650 for them.

CMS counts 276 Medicare patients who saw Ahmed Al-Chalabi in 2024. The largest group is 65 to 74, with 124 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Ahmed Al-Chalabi's median patient age at 64, with 54% women.

In 2024, Ahmed Al-Chalabi wrote 378 Medicare Part D claims for 222 patients. 72% of them were for generic drugs. CMS names the drug for 303 of them, across 10 drugs with 11 or more claims each, at $43,575 in total drug cost. In 2023, CMS named 248 claims across 8 drugs.

Ahmed Al-Chalabi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Ahmed Al-Chalabi as offering telehealth. CMS counts 423 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Ahmed Al-Chalabi, more than 98% of the clinicians it reports for that procedure.

CMS Open Payments shows 60 general payments to Ahmed Al-Chalabi from 7 drug and device companies from 2017 to 2025. Travel and lodging make up the largest share, 81% of the total. Olympus Corporation of the Americas paid the most, $3,941.